Eur J Pediatr Surg 2010; 20(6): 414-415
DOI: 10.1055/s-0030-1254163
Case Gallery
© Georg Thieme Verlag KG Stuttgart · New York

Effectiveness of Propranolol in a Newborn with Liver Hemangiomatosis

L. Meyer1 , H. Graffstaedt2 , H. Giest2 , J. Truebenbach3 , M. Waner4
  • 1St. Joseph Hospital, Pediatric Surgery, Berlin, Germany
  • 2Center for Vascular Malformations in Children (ZVM) in the Department of Pediatric Surgery, St. Joseph Hospital Berlin, Germany
  • 3Center for Diagnostic Radiology & Minimally Invasive Therapy, St. Joseph Hospital Berlin, Germany
  • 4Vascular Birthmark Institute of New York, St. Luke's / Roosevelt Hospital Center,Otorhinolaryngology, New York City, United States
Weitere Informationen


13. Juli 2010 (online)


Infantile hemangiomas (IH) are common in newborns (about 3%), with a higher incidence in low birth weight infants [1]. Disseminated forms with several hemangiomas (more than 5) in one individual are much rarer. They are classified as purely cutaneous hemangiomatosis, combined cutaneous and visceral hemangiomatosis or purely visceral hemangiomatosis. Segmental hemangiomas may also show associated visceral involvement [2]. Cutaneous forms are generally benign and regress spontaneously. Cases of visceral involvement with many liver arteriovenous fistulas may cause high output cardiac failure with life-threatening consequences. To treat progressive congestive heart failure, many therapies have been introduced: hepatic artery ligation (first report in 1967) [3] [4] [5], radiation therapy [6], partial liver resection [7], special compression sutures for affected liver tissue [8], arterial hepatic embolization [9], urgent liver transplantation [10] and various medical treatments with prednisone, interferon alpha 2a [11], cyclophosphamide [12] [13] [14] and vincristine [15]. In June 2008, 2 French groups from Montpellier and Bordeaux presented their first compelling results on the treatment of IH with a non-selective beta-blocker at the 17th International Workshop of the International Society for the Study of Vascular Anomalies (ISSVA) in Boston [16]. We subsequently began to treat infants with IH in 2008 with encouraging results. In 2009 we introduced propranolol to treat a patient with liver hemangiomatosis.


  • 1 Drolet BA, Swanson EA, Frieden IJ. Hemangioma Investigator Group. Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants.  J Pediatr. 2008;  153 712-715
  • 2 Metry DW, Hawrot A, Altman C. et al . Association of solitary, segmental hemangiomas of the skin with visceral hemangiomatosis.  Arch Dermatol. 2004;  140 591-596
  • 3 Laird WP, Friedman S, Koop CE. et al . Hepatic hemangiomatosis. Successful management by hepatic artery ligation.  Am J Dis Child. 1976;  130 657-659
  • 4 de Lorimier AA, Simpson EB, Baum RS. et al . Hepatic-artery ligation for hepatic hemangiomatosis.  N Engl J Med. 1967;  277 333-337
  • 5 Moazam F, Rodgers BM, Talbert JL. Hepatic artery ligation for hepatic hemangiomatosis of infancy.  J Pediatr Surg. 1983;  18 120-123
  • 6 Rotman M, John M, Stowe S. et al . Radiation treatment of pediatric hepatic hemangiomatosis and coexisting cardiac failure.  N Engl J Med. 1980;  302 852
  • 7 Young RS, Zalneraitis EL, Bauman ML. Disseminated neonatal hemangiomatosis: successful hepatic resection with subsequent development of hydrocephalus.  J Pediatr Surg. 1981;  16 752-753
  • 8 Rokitansky AM, Jakl RJ, Göpfrich H. et al . Special compression sutures: a new surgical technique to achieve a quick decrease in shunt volume caused by diffuse hemangiomatosis of the liver.  Pediatr Surg Int. 1998;  14 119-121
  • 9 Stratte EG, Tope WD, Johnson CL. et al . Multimodal management of diffuse neonatal hemangiomatosis.  J Am Acad Dermatol. 1996;  34 337-342
  • 10 Markiewicz-Kijewska M, Kasprzyk W, Broniszczak D. et al . Hemodynamic failure as an indication to urgent liver transplantation in infants with giant hepatic hemangiomas or vascular malformations – Report of 4 cases.  Pediatr Transplant. 2008;  25 [Epub ahead of print]
  • 11 Le Luyer B, Duquenoy A, Poinsot J. et al . Use of interferon in a case of hepatic hemangioma.  Arch Pediatr. 2000;  7 1201-1204
  • 12 Gottschling S, Schneider G, Meyer S. et al . 2 infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide.  Pediatr Blood Cancer. 2006;  46 239-242
  • 13 Hurvitz SA, Hurvitz CH, Sloninsky L. et al . Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver.  J Pediatr Hematol Oncol. 2000;  22 527-532
  • 14 Sovinz P, Urban C, Hausegger K. Life-threatening hemangiomatosis of the liver in an infant: multimodal therapy including cyclophosphamide and secondary acute myeloid leukemia.  Pediatr Blood Cancer. 2006;  47 972-973
  • 15 Enjolras O, Brevière GM, Roger G. et al . Vincristine treatment for function- and life-threatening infantile hemangioma.  Arch Pediatr. 2004;  11 99-107
  • 16 Léauté-Labrèze C, Dumas de la Roque E, Hubiche T. et al . Propranolol for severe hemangiomas of infancy.  N Engl J Med. 2008;  358 2649-2651


Lutz MeyerMD 

St. Joseph Hospital

Pediatric Surgery

Wuesthoffstraße 15

12101 Berlin


Telefon: +49 30 7882 2127

Fax: +49 30 7882 2696